Autoantibodies from patients with idiopathic ataxia bind to M-phase phosphoprotein-1 (MPP1)

Journal of Investigative Medicine

Volumn 48, Issue 1, 2000, Pages 28-39

  Fritzler, Marvin J ^b   Kerfoot, Steven M ^c   Feasby, Thomas E ^c   Zochodne, Douglas W ^c   Westendorf, Joanne M ^c   Dalmau, Josep O ^c   Chan, Edward K L ^a  

^a SCRIPPS RESEARCH INSTITUTE   (United States)

^b UNIVERSITY OF CALGARY   (Canada)

^c NONE

Author keywords

Ataxia; Autoimmune diseases; Neuropathy; Recombinant protein

Indexed keywords

AUTOANTIBODY; CELL CYCLE PROTEIN; COMPLEMENTARY DNA; NUCLEAR PROTEIN; PHOSPHOPROTEIN; RECOMBINANT PROTEIN;

ANIMAL EXPERIMENT; ANTIGEN BINDING; ARTICLE; ATAXIA; CELL STRAIN HEPG2; CONTROLLED STUDY; FEMALE; GUINEA PIG; HELA CELL; HUMAN; HUMAN CELL; IMMUNOFLUORESCENCE; IMMUNOPRECIPITATION; MAJOR CLINICAL STUDY; MITOSIS; MULTIPLE SCLEROSIS; NONHUMAN; NUCLEOTIDE SEQUENCE; PERIPHERAL NEUROPATHY; PROTEIN BINDING; PROTEIN PHOSPHORYLATION; SENSORY NEUROPATHY;

ANIMALIA; ATAXIA; ATAXIA TELANGIECTASIA; CAVIA PORCELLUS; SUS SCROFA;

EID: 0033915188     PISSN: 17088267     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (88)

1. von Muhlen CA, Tan EM. Autoantibodies in the diagnosis of systemic rheumatic disease. Semin Arthritis Rheum 1995;24:323-58.
2. Fritzler MJ, Andrade LEC. Antibodies to non-histone antigens in systemic lupus erythematosus. In: Lahita R, ed. Systemic lupus erythematosus. New York: Academic Press, 1998:247-67.
3. Volpé R. Autoimmune endocrinopathies: aspects of pathogenesis and the role of immune assays in investigation and management. Clin Chem 1994;40:2132-45.
4. von Muhlen CA, Chan EKL, Angles-Cano E, Mamula MJ, Garcia-de la Torre I, Fritzler MJ. Advances in autoantibodies in SLE. Lupus 1998;7:507-14.
5. Dalmau J, Gultekin HS, Posner JB. Paraneoplastic neurologic syndromes: pathogenesis and physiopathology. Brain Pathol 1999;9:275-84.
6. Ropper AH, Gorson KC. Neuropathies associated with paraproteinemia. N Engl J Med 1998;338:1601-7.
7. Spadaro M, Amendolea MA, Mazzucconi MG, Fantozzi R, Di Lello R, Zangari P, Masala C. Autoimmunity in multiple sclerosis: study of a wide spectrum of autoantibodies. Mult Scler, 1999;5:121-5.
8. 1 antibody testing. Muscle Nerve 1994;17:100-4.
9. Pestronk A, Choksi R, Bieser K, Goldstein JM, Adler CH, Caselli RJ, George EB. Treatable gait disorder and polyneuropathy associated with high titer serum IgM binding to antigens that copurify with myelin-associated glycoprotein. Muscle Nerve 1994;17:1293-1300.
10. Solimena M, De Camilli P. Autoimmunity to glutamic acid decarboxylase (GAD) in stiff-man syndrome and insulin-dependent diabetes mellitus. Trends Neurosci 1991;14:452-7.
11. Pelucchi A, Ciceri E, Clementi F, Marazzini L, Foresi A, Sher E. Calcium channel autoantibodies in myasthenic syndrome and small cell lung cancer. Am Rev Respir Dis 1993;147:1229-32.
12. Lindsey JW, Albers GW, Steinman L. Recurrent transverse myelitis, myasthenia gravis, and autoantibodies. Ann Neurol 1992;32: 407-9.
13. Connolly AM, Dodson WE, Prensky AL, Rust RS. Course and outcome of acute cerebellar ataxia. Ann Neurol 1994;35:673-9.
14. Fife TD, Balch RW. Disequilibriumn of unknown cause in older people. Ann Neurol 1993;34:694-702.
15. Victor M, Ferrendelli JA. The nutritional and metabolic diseases of the cerebellum: clinical and pathological aspects. In: Field WS, Willis WD, eds. The cerebellum in health and disease. St. Louis: Warren H. Gree Inc., 1970:412-49.
16. Torvik A, Torp S, Lindboe CF. Atrophy of the cerebellar vermis in aging: a morphometric and histologic study. J Neurol Sci 1986;76: 283-94.
17. Bertini E, Cusmai R, deSaint Basile G, Le Deist F, diCapua M, Gaggero DR, Dionisi-Vice C, Santillo C, Ceniglia M. Congenital X-linked ataxia, progressive myoclonic encephalopathy, macular degeneration and recurrent infections. Am J Med Gen 1992;43:443-51.
18. Campanella G, Filla A, deMichele G. Classifications of hereditary ataxias. A critical overview. Acta Neurol 1992;14:408-19.
19. Hadjivassiliou M, Grunewald RA, Chattopadhyay AK, Davies-Jones GAB, Gibson A, Jarratt JA, Kandler RH, Lobo A, Powell T, Smith CML. Clinical, radiological, neurophysiological, and neuropathological characteristics of gluten ataxia. Lancet 1998;352:1582-5.
20. Ito H, Sayama S, Kanazawa N, Saito T, Kowa H, Haga S, Ikeda K. Antineuronal antibodies in acute cerebellar ataxia following Epstein-Barr virus infection. Neurology 1994;44:1506-7.
21. Peters ACB, Versteeg J, Lindeman J, Bots GTAM. Varicella and acute cerebellar ataxia. Arch Neurol 1978;35:769-71.
22. Fleischer G, Henry W, McSorley M, Arbeter A, Plotkin S. Life-threatening complications of varicella. Am J Dis Child 1981;135: 896-9.
23. Sriram S, Steinman L. Postinfectious and postvaccinial encephalomyelitis. Neurol Clinics 1984;2:341-53.
24. Reilly K, Cohen-Sobel E, Caselli M. Ataxic gait. Complication of chicken pox. J Am Ped Med Assoc 1993;83:161.
25. Shoji H, Hirai S, Ishakawa K, Aramaki M, Sato Y, Abe T, Kojima K. CT and MR imaging of acute cerebellar ataxia. Neuroradiology 1991;33:360-1.
26. de Silva HJ, Hoang P, Dalton H, de Silva R, Jewell DP, Pieries JB. Immune activation during cerebellar dysfunction following Plasmodium falciparum malaria. Trans R Soc Trop Med Hyg 1992;86:129-31.
27. Aufricht CA, Tenner W, Stiglbauer R, Rosenmayr F. Transient cerebellopontine demyelination revealed by MRI in acute cerebellar ataxia. Pediatr Radiol 1990;20:602-3.
28. Groen RJM, Begeer JH, Wilmink JT, le Coultre R. Acute cerebellar ataxia in a child with transient pontine lesions demonstrated by MRI. Neuropediatrics 1991;22:225-7.
29. Dalmau JO, Posner JB. Paraneoplastic syndromes. Arch Neurol 1999;56:405-8.
30. Darnell RB. The importance of defining the paraneoplastic neurologic disorders. N Engl J Med 1999;340:1831-3.
31. Brain L, Wilkinson M. Subacute cerebellar degeneration associated with neoplasm. Brain 1965;88:465-78.
32. Anderson NE, Rosenblum MK, Posner JB. Paraneoplastic cerebellar degeneration: clinical-immunological correlations. Ann Neurol 1988;24:559-67.
33. Posner J. Paraneoplastic cerebellar degeneration. Can J Neurol Sci 1993;20:S117-S122.
34. Horwich MS, Cho L, Porro RS, Posner JB. Subacute sensory neuropathy: a remote effect of cancer. Ann Neurol 1977;2:7-19.
35. Dalmau J, Furneaux HM, Gralla RJ, Kris MG, Posner JB. Detection of the anti-Hu antibody in the serum of patients with small cell lung cancer - a quantitative western blot analysis. Ann Neurol 1990;27: 544-52.
36. Graus F, Elkon KB, Lloberes P, Ribalta T, Torres A, Ussetti P, Vails J, Obach J, Agusti-Vidal A. Neuronal antinuclear antibody (anti-Hu) in paraneoplastic encephalomyelitis simulating acute, polyneuritis. Acta Neurol Scand 1987;75:249-52.
37. Anderson NE, Rosenblum MK, Graus F, Wiley RG, Posner JB. Autoantibodies in paraneoplastic syndromes associated with small-cell lung cancer. Neurology 1988;38:1391-8.
38. Graus F, Elkon KB, Posner JB. Sensory neuropathy and small cell lung cancer. Antineuronal antibody that also react with the tumor. , Am J Med 1986;80:45-52.
39. Voltz R, Gultekin SH, Rosenfeld MR, Gerstner E, Eichen J, Posner JB, Dalmau J. A serologic marker of paraneoplastic limbic and brain-stem encephalitis in patients with testicular cancer. N Engl J Med 1999;340:1788-95.
40. Buckanovich RJ, Posner JB, Darnell RB. Nova, the paraneoplastic Ri antigen, is homologous to an RNA-binding protein and is specifically expressed in the developing motor system. Neuron 1993;11: 657-72.
41. Buckanovich RJ, Yang YYL, Darnell RB. The onconeural antigen Nova-1 is a neuron-specific RNA-binding protein, the activity of which is inhibited by paraneoplastic antibodies. J Neurosci 1996;16: 1114-22.
42. Westendorf JM, Rao PN, Gerace L. Cloning of cDNAs for M-phase phosphoproteins recognized by the MPM2 monoclonal antibody and determination of the phosphorylated epitope. Proc Natl Acad Sei USA 1994;91:714-8.
43. Fritzler MJ, Pauls JD, Kinsella TD, Bowen TJ. Antinuclear, anticytoplasmic and anti-Sjögren's syndrome antigen-A (SS-A/Ro) antibodies in female blood donors. Clin Immunol Immunopathol 1985;36: 120-8.
44. Fritzler MJ, Hamel JC, Ochs RL, Chan EKL. Molecular characterization of two human autoantigens: unique cDNAs encoding 95-and 160-kD proteins of a putative family in the Golgi complex. J Exp Med 1993;178:49-62.
45. Bonner J, Dahmus ME, Fambrough DM, Huang RC, Marushige K, Tuan DHY. The biology of isolated chromatin. Science 1968;159: 47-56.
46. Adam SA, Nakagawa T, Swanson MS, Woodruff TK, Dreyfuss G. mRNA polyadenylate binding protein: gene isolation and sequencing and identification of a ribonucleoprotein consensus sequence. Mol Cell Biol 1986;6:2932-43.
47. Devereux J, Haeberli P, Smithies O. A comprehensive set of sequence analysis programs for the VAX. Nucleic Acids Res 1984;12: 387-95.
48. Altschul SF, Gish W, Miller W, Myers EW, Lipman DJ. Basic local alignment search tool. J Mol Biol 1990;215:403-10.
49. Lupas A, Van Dyke M, Stock J. Predicting coiled coils from protein sequences. Science 1991;252:1162-4.
50. Berger B, Wilson D, Wolf E, Tonchev T, Milla M, Kim P. Predicting coiled coils by use of pairwise residue correlations. Proc Natl Acad Sci USA 1995;92:8259-63.
51. Sakai K, Mitchell DJ, Tsukamoto T, Steinman L. Isolation of a complementary DNA clone encoding an autoantigen recognized by an anti-neuronal cell antibody from a patient with paraneoplastic cerebellar degeneration. Ann Neurol 1990;28:692-8.
52. Yen TJ, Li G, Schaar BT, Szilak I, Cleveland DW. CENP-E is a putative kinetochore motor that accumulates just before mitosis. Nature 1992;359:536-9.
53. Kiers L, Altermatt HJ, Lennon VA. Paraneoplastic anti-neuronal nuclear IgG autoatnibodies (Type I) localize antigen in small cell lung carcinoma. Mayo Clin Proc 1991;66:1209-16.
54. Kuang J, Zhao J-Y, Wright DA, Saunders GF, Rao PN. Mitosis-specific monoclonal antibody MPM-2 inhibits Xenopus oocyte maturation and depletes maturation-promoting activity. Proc Natl Acad Sci USA 1989;86:4982-6.
55. Davis FM, Rao PN. Antibodies to mitosis-specific phosphoproteins. In: Schlegel RA, ed. Molecular regulation of nuclear events in mitosis and meiosis. New York: Academic Press, 1987:259.
56. Davis FM, Tsao TY, Fowler SK, Rao PN. Monoclonal antibodies to mitotic cells. Proc Natl Acad Sci USA 1983;80:2926-30.
57. Vandre DD, Davis FM, Rao PN, Borisy GG. Phosphoproteins are components of mitotic microtubule organizing centers. Proc Natl Acad Sci USA 1984;81:4439-43.
58. Zhao L, Kuang J, Adlakha RC, Rao PN. Threonine phosphorylation is associated with mitosis in HeLa cells. FEBS Lett 1989;249: 389-95.
59. Westendorf JM, Konstantinov KN, Wormsley S, Shu M-D, Matsumoto-Taniura N, Priollet F, Klier FG, Gerace L, Baserga SJ. M phase phosphoprotein 10 is a human U3 small nucleolar ribonucleoprotein component. Mol Biol Cell 1998;9:437-49.
60. Matsumoto-Taniura N, Monroe R, Gerace L, Westendorf JM. Identification of novel M phase phosphoproteins by expression cloning. Mol Biol Cell 1996;7:1455-69.
61. Engle DB, Doonan JH, Morris NR. Cell-cycle modulation of MPM-2 specific spindle pole body phosphorylation in Aspergillus nidulans. Cell Motil Cytoskeleton 1988;10:432-7.
62. Kuang J, Ashorn CL, Gonzales-Kuyvenhoven M, Penkala JE. cdc25 is one of the MPM-2 antigens involved in the activation of maturation-promoting factor. Mol Biol Cell 1994;5:135-45.
63. Vandre DD, Centonze VE, Peloquin J, Tombes RM, Borisy GG. Proteins of the mammalian mitotic spindle: phosphorylation/ dephosphorylation of MAP-4 during mitosis. J Cell Sci 1991;98:577-88.
64. Taagepera S, Rao PN, Drake FH, Gorbsky GJ. DNA topoisomerase IIα is the major chromosome protein recognized by the mitotic phosphoprotein antibody MPM-2. Proc Natl Acad Sei USA 1993;90: 8407-11.
65. Kuang J, Penkala JE, Wright DA, Saunders GF, Rao PN. A novel M phase-specific H1 kinase recognized by the mitosis-specific monoclonal antibody MPM-2. Devel Biol 1991;144:54-64.
66. Chan EKL, Fritzler MJ. Autoantibodies to Golgi apparatus antigens. In: Conrad K, Humbel R-L, Meurer M, Shoenfeld Y, Tan EM, eds. Pathogenic and diagnostic relevance of autoantibodies. Proceedings 4th Dresden symposium on autoantibodies. Scottsdale, Ariz: Pabst Scientific Publishers, 1998:85-100.
67. Chan EKL, Hamel JC, Buyon JP, Tan EM. Molecular definition and sequence motifs of the 52-kD component of human SS-A/Ro autoantigen. J Clin Invest 1991;87:68-76.
68. Yang CH, Lambie EJ, Snyder M. NuMA. An unusually long coiled-coil related protein in the mammalian nucleus. J Cell Biol 1992116:1303-17.
69. Yaneva M, Wen J, Ayala A, Cook R. cDNA-derived amino acid sequence of the 86-kDa subunit of the Ku antigen. J Biol Chem 1989; 264:13407-11.
70. Chou C-H, Reeves WH. Recognition of multiple epitopes in the coiled-coil domain of lamin B by human autoantibodies. Mol Immunol 1992;29:1055-64.
71. Pollard KM, Chan EKL, Grant BJ, Sullivan KF, Tan EM, Glass CA. In vitro posttranslational modification of lamin B cloned from a human T-cell line. Mol Cell Biol 1990;10:2164-75.
72. Cunningham MW, Antone SM, Gulizia JM, McManus BA, Gauntt CJ. α-helical coiled-coil molecules: a role in autoimmunity against the heart. Clin Immunol Immunopathol 1993;68:118-23.
73. McCormack JM, Crossley CA, Ayoub EM, Harley JB, Cunningham MW. Poststreptococcal anti-myosin antibody idiotype associated with systemic lupus erythematosus and Sjogren's syndrome. J Infect Dis 1993;168:915-21.
74. Liao H, Winkfein RJ, Mack G, Rattner JB, Yen TJ. CENP-F is a protein of the nuclear matrix that assembles onto kinetochores at late G2 and is rapidly degraded after mitosis. J Cell Biol 1995;130: 507-18.
75. Selak S, Scheonroth L, Senecal J-L, Fritzler MJ. Early endosome antigen 1: an autoantigen associated with neurological diseases. J Investig Med 1999;47:311-8.
76. Landschulz WH, Johnson PF, McKnight SL. The leucine zipper: a hypothetical structure common to a new class of DNA binding proteins. Science 1988;240:1759-64.
77. Britton P. Coronavirus motif. Nature 1991;353:394.
78. Buckland R, Wild F. Leucine zipper extends. Nature 1989;338: 547.
79. Reyneir MO, Hashieh IA, Crotte C, Carbuccia N, Richard B, Gerolami A. Monensin action on the Golgi complex in perfused rat liver: evidence against bile salt vesicular transport. Gastroenterology 1992; 102: 2024-32.
80. Abel T, Maniatis T. Action of leucine zippers. Nature 1989;341: 24-5.
81. Landschulz WH, Johnson PF, Adashi E, Graves BJ, McKnight SL. Isolation of a recombinant copy of the gene encoding C/EBP. Genes Dev 1988;2:786-800.
82. Buckland R, Malvoisin E, Beauverger P, Wild F. A leucine zipper structure present in the measles virus fusion protein is not required for its tetramerization but is essential for fusion. J Gen Virol 1992;73: 1703-7.
83. Delwart E, Mosialos G. Retroviral envelope glycoproteins contain a leucine zipper-like retreat. AIDS Res Human Retroviruses 1990; 6:703-6.
84. Tucker S, Srinivas R, Copmans R. Molecular domains involved in oligomerization of the Friend leukemia virus envelope protein. Virology 1991;16:2431-44.
85. Chan EKL, Andrade LEC. Antinuclear antibodies in Sjögren's syndrome. Rheum Dis Clin North Am 1992;18:551-70.
86. Landberg G, Tan EM, Roos G. Flow cytometric multiparameter analysis of proliferating cell nuclear antigen/cyclin and Ki-67 antigen: a new view of the cell cycle. Exp Cell Res 1990;187:111-8.
87. Brashear RH, Greenlee JE, Jaeckle KA. Anticerebellar antibodies in neurologically normal patients with ovarian neoplasms. Neurology 1989;39:1605-9.
88. Martin L, Fritzler MJ. Autoantibodies. In: Stein JH, ed. Stein's internal medicine. Boston: Little, Brown & Co., 1998;1155-60.